Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG
NEW YORK, May 22, 2013
NEW YORK, May 22, 2013 /PRNewswire/ -- Attorney Advertising --Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims on behalf of
purchasers of the securities of AMAG Pharmaceuticals, Inc. ("AMAG" or the
"Company") (NasdaqGS: AMAG -News). The investigation focuses on whether the
Company and its executives violated federal securities laws.
On May 22, 2013, Shares of AMAG dropped $2.69 or 10.73% during intraday
trading after the company announced in regulatory filing that it has been made
aware by Takeda Pharmaceutical Company Limited, the exclusive product
distributor of ferumoxytol in Switzerland, that it is recalling one specific
batch of Rienso, ferumoxytol, from the Swiss market. This decision is based on
a cluster of four post-marketing adverse event reports in Switzerland
concerning hypersensitivity reactions of varying severity following the
administration of Rienso from this batch. One of these cases included a
report of a fatality.
If you are aware of any facts relating to this investigation, or purchased
shares of AMAG, you can assist this investigation by contacting Peretz
Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein,
Gewirtz & Grossman, LLC at 212-697-6484 or via email email@example.com. Those
who inquire by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our
primary expertise is the aggressive pursuit of litigation claims on behalf of
our clients. In addition to representing institutions and other investor
plaintiffs in class action security litigation, the firm's expertise includes
general corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not guarantee similar
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein 212-697-6484
SOURCE Bronstein, Gewirtz & Grossman, LLC
Press spacebar to pause and continue. Press esc to stop.